olopatadine hydrochloride ophthalmic solution 0.7%

DRUG2 trials

Sponsors

Clinical Research Center of Florida, Andover Research Eye Institute

Conditions

Allergic ConjunctivitisBilateral Conjunctivitis (Disorder)

Phase 4

DEXTENZA Therapy for Treatment of Allergic Conjunctivitis

CompletedNCT04708821

Clinical Research Center of FloridaBilateral Conjunctivitis (Disorder)

Start: 2021-04-30End: 2021-09-02Updated: 2022-04-13

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis

CompletedNCT05265910

Andover Research Eye InstituteAllergic Conjunctivitis

Start: 2021-12-14End: 2022-04-23Updated: 2022-05-03